| 676 |
Mitochondrial ETC inhibitors
|
|
None
|
| 854 |
ML385
|
|
615: Suppression of Keap1 cysteine oxidation leading to liver inflammation
|
| 684 |
Molinate
|
-
Molinate, CAS-RN: 2212-67-1, DTXSID6024206
|
None
|
| 64 |
Mono(2-ethylhexyl) phthalate
|
|
457: Succinate dehydrogenase inhibition leading to increased insulin resistance through reduction in circulating thyroxine
|
| 569 |
monobenzyl phthalate
|
|
None
|
| 692 |
Montelukast
|
-
Montelukast, CAS-RN: 158966-92-8, DTXSID9023334
|
None
|
| 222 |
MPP+
|
|
3: Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits
|
| 403 |
MS-275
|
-
MS-275, CAS-RN: 209783-80-2, DTXSID0041068
|
274: Histone deacetylase inhibition leads to impeded craniofacial development
|
| 306 |
Multi-walled carbon nanotubes
|
|
409: Frustrated phagocytosis leads to malignant mesothelioma
|
| 847 |
Muristerone A
|
|
342: Ecdysone receptor hyperactivation leading to mortality via mis-timed activation of nuclear receptor cascade
|
| 669 |
Mycotoxin
|
-
Mycotoxin, CAS-RN: NOCAS, DTXSID0040884
|
None
|
| 572 |
N-(5-Hydroxytricyclo[3.3.1.13,7]dec-2-yl)-α,α-dimethyl-4-[5-(trifluoromethyl)-2-pyridinyl]-1-piperazineacetamide
|
|
348: Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory
|
| 80 |
N-methyl Carbamates
|
|
405: Organo-Phosphate Chemicals induced inhibition of AChE leading to impaired cognitive function
|
| 833 |
N-Methyl-D-aspartic acid
|
-
N-Methyl-D-aspartic acid, CAS-RN: 6384-92-5, DTXSID8041082
|
475: Binding of chemicals to ionotropic glutamate receptors leads to impairment of learning and memory via loss of drebrin from dendritic spines of neurons
|
| 268 |
n/a
|
|
None
|
| 589 |
Nʹ-((4-Oxo-4H-chromen-3-yl)methylene)nicotinohydrazide
|
|
None
|
| 588 |
Nʹ-((4-Oxo-4H-chromen-3-yl)methylene)nicotinohydrazide Pimozide
|
|
None
|
| 315 |
Nabam-sodium
|
-
Nabam-sodium, CAS-RN: 142-59-6, DTXSID5020603
|
242: Inhibition of lysyl oxidase leading to enhanced chronic fish toxicity
|
| 206 |
Nafenopin
|
-
Nafenopin, CAS-RN: 3771-19-5, DTXSID8020911
|
37: PPARα activation leading to hepatocellular adenomas and carcinomas in rodents
|
| 634 |
nanomaterials
|
|
2 AOPs
|
| 224 |
nanoparticles
|
|
3 AOPs
|
| 733 |
Nanoparticles and micrometer
|
|
None
|
| 717 |
Nanoparticles and Micrometer Particles
|
|
None
|
| 230 |
naphtharazine
|
|
None
|
| 41 |
Naproxen
|
-
Naproxen, CAS-RN: 22204-53-1, DTXSID4040686
|
None
|